How Fructose Metabolism in Immune Cells Drives Glioblastoma Growth

A study reveals that immune cells within brain tumors metabolize fructose, suppressing immune response and promoting glioblastoma growth. Blocking fructose metabolism improved immunotherapy response in mice. The finding suggests fructose metabolism in microglia as a therapeutic target to enhance treatment effectiveness against this aggressive brain cancer.

Researchers have uncovered a crucial link between fructose metabolism in immune cells and the growth of glioblastoma, a highly aggressive brain tumor. The new study, published in the Proceedings of the National Academy of Sciences, indicates that specialized immune cells called microglia utilize a unique fructose transporter, GLUT5, to metabolize sugar, thereby suppressing immune response and facilitating tumor growth.

In experimental models, genetically eliminating the GLUT5 transporter led to a significant immune activation, characterized by enhanced T-cell responses and increased inflammatory markers, which collectively hindered tumor progression. This observation highlights the potential of targeting microglial fructose metabolism to improve patient outcomes through more effective immunotherapy.

The research underscores the intricate interplay between tumor microenvironments and the immune system, suggesting that the suppression of GLUT5-dependent fructose metabolism can serve as a promising therapeutic strategy against treatment-resistant glioblastoma, offering renewed hope for patients battling this formidable disease.